|
T13783
|
|
|
Others
|
| MT-4 可阻断肿瘤细胞和肿瘤niche 表面的TG2/FN 复合体。 MT-4抑制卵巢癌(OC)细胞与腹膜的黏附。 |
|
T61395
|
|
|
|
| Mt KARI-IN-4 (compound 5c) is a highly effective inhibitor of Mycobacterium tuberculosis ketol-acid reductoisomerase (Mtb KARI), demonstrating a Ki value of 5.48 μM. Additionally, Mt KARI-IN-4 displays inhibitory properties against Mtb H37Rv, with a minimum inhibitory concentration (MIC) of 0.78 μM. Importantly, this compound exhibits low levels of cytotoxicity, as evident from its half-maximal inhibitory concentration (IC 50 ) value of over 72 μg/mL against human embryonic kidney cells (HEK) [1]. |
|
T11465
|
|
|
Others
HIV Protease
|
| Lenacapavir 是一种有效的靶向衣壳的 HIV 复制抑制剂。 Lenacapavir 在 MT-4 细胞中显示出抗 HIV 活性，EC50 为 100 pM。 |
|
T67833
|
|
|
HIV Protease
|
| HIV-1 inhibitor-54 是一种有效的 HIV-1 抑制剂，在 MT-4 细胞中对 WT HIV-1 (菌株 IIIB) x 显示出抗 HIV 活性（EC50 ： 32 nM）。HIV-1 inhibitor-54 可用于研究病毒感染。 |
|
TQ0174
|
|
|
CXCR
|
| Mavorixafor 是一种有效的特异性 CXCR4 拮抗剂，对 CXCR4 125I-SDF 结合的 IC50 值为 13 nM。 Mavorixafor 在 MT-4 细胞 (IC50 = 1 nM) 和 PBMC (IC50 = 9 nM) 中抑制 T-tropic HIV-1 (NL4.3 株) 的复制。 |
|
T9104
|
|
|
Apoptosis
|
| TJ191 是一种选择性抗癌试剂，靶向低 TβRIII 表达的恶性T 细胞白血病/淋巴瘤细胞，可研究癌症。 |
|
T7519
|
|
|
5-HT Receptor
|
| RS 127445 是一种可口服的，高亲和力选择性5-HT2B 受体拮抗剂，pKi 为 9.5，比作用于其他受体和离子通道的选择性高 1000 倍。 |
|
T10141
|
|
|
Others
|
| 4'-Ethynyl-2'-deoxyadenosine (4'-E-dA) is a nucleoside reverse transcriptase (RT) inhibitor. It is potent against drug-resistant HIV variants (EC50: 98 nM in MT-4 cells for anti-HIV-1 activity). |
|
T29393
|
|
|
|
| 3'-Deoxy-4-thiothymidine can moderately active in protecting HIV-induced cytopathogenicity of MT-2 and CEM cells. |
|
T15045
|
|
|
Others
|
| D77 is anti-HIV-1 inhibitor. D77 inhibits HIV-1(IIIB) replication by EC50 value of 23.8 μg/ml in MT-4 cell (5.03 μg/ml for C8166 cells). |
